Akebia

Wipfli Fiscal Advisors LLC acquired a new stake in shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA – Get Score) through the 3rd quarter, in accordance to the organization in its most modern disclosure with the SEC. The fund bought 200,000 shares of the biopharmaceutical firm’s stock, valued at close to $63,000. […]